BNP Paribas Financial Markets purchased a new stake in monday.com Ltd. (NASDAQ:MNDY – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 279,895 shares of the company’s stock, valued at approximately $65,898,000. BNP Paribas Financial Markets owned 0.58% of monday.com at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Clearbridge Investments LLC lifted its position in shares of monday.com by 0.3% during the 4th quarter. Clearbridge Investments LLC now owns 13,501 shares of the company’s stock valued at $3,179,000 after acquiring an additional 44 shares during the period. Prudential Financial Inc. lifted its position in monday.com by 1.3% during the fourth quarter. Prudential Financial Inc. now owns 4,122 shares of the company’s stock worth $970,000 after purchasing an additional 53 shares during the period. Global Retirement Partners LLC lifted its position in monday.com by 64.8% during the fourth quarter. Global Retirement Partners LLC now owns 150 shares of the company’s stock worth $35,000 after purchasing an additional 59 shares during the period. Venturi Wealth Management LLC grew its stake in monday.com by 7.6% during the fourth quarter. Venturi Wealth Management LLC now owns 1,076 shares of the company’s stock worth $253,000 after buying an additional 76 shares in the last quarter. Finally, Vestcor Inc increased its holdings in monday.com by 16.0% in the 4th quarter. Vestcor Inc now owns 602 shares of the company’s stock valued at $142,000 after buying an additional 83 shares during the period. Institutional investors and hedge funds own 73.70% of the company’s stock.
monday.com Price Performance
Shares of MNDY stock opened at $275.94 on Wednesday. The stock has a market capitalization of $14.01 billion, a PE ratio of 459.90, a PEG ratio of 16.53 and a beta of 1.32. The business’s 50 day simple moving average is $256.00 and its 200 day simple moving average is $265.66. monday.com Ltd. has a one year low of $180.66 and a one year high of $342.64.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on MNDY. Robert W. Baird upped their price target on shares of monday.com from $275.00 to $335.00 and gave the stock a “neutral” rating in a report on Tuesday, February 11th. KeyCorp upgraded monday.com from a “sector weight” rating to an “overweight” rating and set a $420.00 target price for the company in a research note on Tuesday, February 11th. Tigress Financial lifted their price target on monday.com from $340.00 to $450.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Barclays upped their price objective on monday.com from $325.00 to $360.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. Finally, Wells Fargo & Company decreased their target price on monday.com from $380.00 to $310.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $342.86.
Read Our Latest Stock Report on monday.com
monday.com Profile
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools.
Featured Stories
- Five stocks we like better than monday.com
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The Top-Ranked Insider Buys From April by Market Cap
- How to find penny stocks to invest and tradeĀ
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for monday.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for monday.com and related companies with MarketBeat.com's FREE daily email newsletter.